Navigation Links
Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
Date:12/1/2009

SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management's presentation at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1 at 11:00 a.m. Eastern Time will be webcast live at www.celltherapeutics.com.

The presentation will take place in Holmes 1 at the New York Palace Hotel, and will also be available for replay after the presentation.


                     Piper Jaffray Health Care Conference
                  New York Palace Hotel, Holmes 1 (4th Floor)
                  CTI Presentation: Tuesday, December 1, 2009
       11:00 a.m. Eastern /5:00 p.m. Central European /8:00 a.m. Pacific
                   Audio webcast at www.celltherapeutics.com


Media Contact:
Dan Eramian
T: 206.272.4343
C: 206.854.1200
F: 206.272.4434
E: deramian@ctiseattle.com
www.celltherapeutics.com/press_room

Investors Contact:
Ed Bell
T: 206.272.4345
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.celltherapeutics.com/investors

SOURCE Cell Therapeutics, Inc.


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Monogram Energy, Inc. Acquires Triad Therapeutics, Inc.
2. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5
3. Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split
4. Cell Therapeutics, Inc. Annual Meeting of Shareholders Scheduled for Tuesday, October 20, 2009
5. Oxygen Biotherapeutics, Inc. to Present at Investor Conferences in Zurich
6. Oxygen Biotherapeutics, Inc. Posts Blog by CEO Chris Stern on Proposed Reverse Split
7. Cell Therapeutics, Inc.s (CTI) Presentation at BioCentury NewsMakers Conference to be Webcast
8. Oxygen Biotherapeutics, Inc. Posts Latest Blog by CEO Chris Stern
9. Cell Therapeutics, Inc.s (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
10. Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
11. Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... In the crowded ... is a stand-out company for several differences from other mainstream brands. , ... demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . It allows them ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... events, Dr. Carol Francis re-releases powerfully uplifting interview with medical expert and prolific ... everyone endure and pass through tough times, Dr. Bernie Siegel energizes listeners to ...
(Date:1/17/2017)... ... ... SunView Software’s Service Smart Technology has been selected as a finalist for ... year, Pink Elephant recognizes a new product or service developed by an IT services ... opportunity. The award highlights original innovations that were released in 2016, either as a ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... enthusiasts at the National Association of Music Merchants (NAMM) winter trade show, Booth ... 2017. , Etymotic’s ER•4® has long been the gold standard for high-definition, in-ear ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with multiple ... new office in San Clemente, California this month. Achieve TMS West is the ... treating individuals struggling with major depression. Depression impacts over 15 million adults in ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global artificial pancreas devices system market to ... Global Artificial Pancreas Devices System Market 2016-2020, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:1/17/2017)... , Jan. 17, 2017 Paragon Bioservices received ... product development services for a variety of ... medical product development activities. The IDIQ mechanism ... pool for task order awards up to $159 ... in manufacturing and process development of biopharmaceuticals, is ...
(Date:1/17/2017)... 2017  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... in a Phase 3 clinical trial comparing the efficacy ... in the prevention of hepatic veno-occlusive disease (VOD) in ... (HSCT) who are at high risk or at very ... will be conducted across approximately 100 medical centers in ...
Breaking Medicine Technology: